Nanjing Zhengke Pharmaceutical

Nanjing Zhengke Pharmaceutical is a China-based pharmaceutical company established in 2001 that specializes in the research, development, manufacturing, and commercialization of chemical drugs. The company maintains a diverse portfolio focusing on high-prevalence therapeutic areas including cardiovascular diseases, digestive system disorders, and anti-infectives. It is particularly recognized for its expertise in complex generic formulations and fixed-dose combinations, such as its Amlodipine Besylate and Atorvastatin Calcium tablets. Operating with multiple GMP-certified production lines, Nanjing Zhengke integrates R&D with large-scale manufacturing to serve the domestic Chinese healthcare market while pursuing international quality standards.